DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
2.55 / 10
Underperform
Fundamental analysis reveals a subpar profile: low Net profit / Total profit ratio (0/10) and negative Asset-MV score (-0.5007) place the stock in challenging quartiles. Only Cash-MV and Inventory turnover show partial redemption, yet overall profitability and asset efficiency remain concerning, supporting an underperform rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight11.15%
1M Return5.20%
Value-0.26
Score1/3
Weight11.15%
1M Return5.20%
Gross profit margin (%)
Value48.17
Score1/3
Weight-0.86%
1M Return-0.54%
Value48.17
Score1/3
Weight-0.86%
1M Return-0.54%
PB-ROE
Value4.01
Score2/3
Weight23.42%
1M Return10.68%
Value4.01
Score2/3
Weight23.42%
1M Return10.68%
Fixed assets turnover ratio
Value28052.73
Score3/3
Weight1.42%
1M Return0.86%
Value28052.73
Score3/3
Weight1.42%
1M Return0.86%
Cash-MV
Value-0.07
Score2/3
Weight16.71%
1M Return7.73%
Value-0.07
Score2/3
Weight16.71%
1M Return7.73%
Inventory turnover ratio
Value111.00
Score3/3
Weight9.79%
1M Return5.26%
Value111.00
Score3/3
Weight9.79%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight16.69%
1M Return7.79%
Value0.46
Score2/3
Weight16.69%
1M Return7.79%
Current assets turnover ratio
Value2.56
Score2/3
Weight1.95%
1M Return1.15%
Value2.56
Score2/3
Weight1.95%
1M Return1.15%
Asset-MV
Value-0.50
Score1/3
Weight20.23%
1M Return8.74%
Value-0.50
Score1/3
Weight20.23%
1M Return8.74%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.49%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.49%
1M Return-0.30%
Revenue-MV
Value-0.26
Score1/3
Weight11.15%
1M Return5.20%
Value-0.26
Score1/3
Weight11.15%
1M Return5.20%
Inventory turnover ratio
Value111.00
Score3/3
Weight9.79%
1M Return5.26%
Value111.00
Score3/3
Weight9.79%
1M Return5.26%
Gross profit margin (%)
Value48.17
Score1/3
Weight-0.86%
1M Return-0.54%
Value48.17
Score1/3
Weight-0.86%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight16.69%
1M Return7.79%
Value0.46
Score2/3
Weight16.69%
1M Return7.79%
PB-ROE
Value4.01
Score2/3
Weight23.42%
1M Return10.68%
Value4.01
Score2/3
Weight23.42%
1M Return10.68%
Current assets turnover ratio
Value2.56
Score2/3
Weight1.95%
1M Return1.15%
Value2.56
Score2/3
Weight1.95%
1M Return1.15%
Fixed assets turnover ratio
Value28052.73
Score3/3
Weight1.42%
1M Return0.86%
Value28052.73
Score3/3
Weight1.42%
1M Return0.86%
Asset-MV
Value-0.50
Score1/3
Weight20.23%
1M Return8.74%
Value-0.50
Score1/3
Weight20.23%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight16.71%
1M Return7.73%
Value-0.07
Score2/3
Weight16.71%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.49%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.49%
1M Return-0.30%
Is DRUG undervalued or overvalued?
- DRUG scores 2.55/10 on fundamentals and holds a Premium valuation at present. Backed by its -27.93% ROE, 0.00% net margin, -84.20 P/E ratio, 12.55 P/B ratio, and -165.67% earnings growth, these metrics solidify its Underperform investment rating.
